Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?

Arthritis Rheum. 2011 Feb;63(2):325-8. doi: 10.1002/art.30135.
No abstract available

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Diphosphonates / therapeutic use*
  • Female
  • Glucocorticoids / adverse effects*
  • Humans
  • Osteoporosis / chemically induced*
  • Osteoporosis / drug therapy*
  • Osteoporotic Fractures / etiology
  • Osteoporotic Fractures / prevention & control
  • Rheumatic Diseases / complications
  • Rheumatic Diseases / drug therapy

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Glucocorticoids